4K True Story

What I don't understand is why the provider community is not being leveraged in the discussion about the 4K tests efficacy. I just did a couple search strings using various 4K inquiries and the top returns are from institutions like Memorial Sloane Kettering and Cleveland Clinic extolling the virtues and importance of this new test. Doesn't it seem like that those voices, skillfully deployed, could be very influential in establishing the legitimacy of 4K? At the very least it would put pressure on regulators like Palmetto and others who might think twice about taking issue with something that has received strong support from experts in the field.

I guess I'm posting this because I was frustrated by the way Rubin et al seem so resigned and low energy in terms of responding to the Palemetto decision. Why don't they fight back with respected voices from the prostate cancer industry that could give a strong rebuke to their bureaucratic quibbling.

It seems the strategy is to rely solely on getting a positive coverage decision from Novartis. That is inadequate in my view. Palmetto has thrown shade all over 4K and it is effecting peoples view of the company. OPK should be gathering and pushing additional positive views from providers to give Novartis more cover and confidence in rendering an opinion that contradicts Palmetto.

This is a fantastic pain sparing, cost saving, quality of life preserving, cutting edge technology. Why aren't they doing more to let the rest of the world know? OPK needs to shift from just responding to situations like this into a much more proactive role and start doing what they can to drive outcomes rather than always finding themselves at the mercy of them.